Skip to content
Bird Rock Bio
  • About Us
    • Overview
    • Our People
    • Board of Directors
  • Our Pipeline
    • Overview
    • Nimacimab
  • News
  • Careers
  • Contact
  • About Us
    • Overview
    • Our People
    • Board of Directors
  • Our Pipeline
    • Overview
    • Nimacimab
  • News
  • Careers
  • Contact

Author: Colleen Daley

Bird Rock Bio Completes Single Ascending Dose Human Clinical Trial for RYI-018; Generates Safety, Tolerability, and Pharmacokinetics Data; Prepares To Initiate Study in Non-Alcoholic Fatty Liver Disease Patients